1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antivirals Revenue
1.4 Market Analysis by Type
1.4.1 Global Antivirals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Generic
1.4.3 Branded
1.5 Market by Application
1.5.1 Global Antivirals Market Share by Application: 2021-2026
1.5.2 HIV
1.5.3 Hepatitis
1.5.4 HSV
1.5.5 Influenza
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Antivirals Market
1.8.1 Global Antivirals Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Antivirals Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Antivirals Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Antivirals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Antivirals Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Antivirals Sales Volume Market Share by Region (2015-2020)
3.2 Global Antivirals Sales Revenue Market Share by Region (2015-2020)
3.3 North America Antivirals Sales Volume
3.3.1 North America Antivirals Sales Volume Growth Rate (2015-2020)
3.3.2 North America Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Antivirals Sales Volume
3.4.1 East Asia Antivirals Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Antivirals Sales Volume (2015-2020)
3.5.1 Europe Antivirals Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Antivirals Sales Volume (2015-2020)
3.6.1 South Asia Antivirals Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Antivirals Sales Volume (2015-2020)
3.7.1 Southeast Asia Antivirals Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Antivirals Sales Volume (2015-2020)
3.8.1 Middle East Antivirals Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Antivirals Sales Volume (2015-2020)
3.9.1 Africa Antivirals Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Antivirals Sales Volume (2015-2020)
3.10.1 Oceania Antivirals Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Antivirals Sales Volume (2015-2020)
3.11.1 South America Antivirals Sales Volume Growth Rate (2015-2020)
3.11.2 South America Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Antivirals Sales Volume (2015-2020)
3.12.1 Rest of the World Antivirals Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Antivirals Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Antivirals Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Antivirals Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Antivirals Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Antivirals Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Antivirals Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Antivirals Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Antivirals Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Antivirals Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Antivirals Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Antivirals Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Antivirals Sales Volume Market Share by Type (2015-2020)
14.2 Global Antivirals Sales Revenue Market Share by Type (2015-2020)
14.3 Global Antivirals Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Antivirals Consumption Volume by Application (2015-2020)
15.2 Global Antivirals Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Antivirals Business
16.1 Merck
16.1.1 Merck Company Profile
16.1.2 Merck Antivirals Product Specification
16.1.3 Merck Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Bristol-Myers-Squibb
16.2.1 Bristol-Myers-Squibb Company Profile
16.2.2 Bristol-Myers-Squibb Antivirals Product Specification
16.2.3 Bristol-Myers-Squibb Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 GSK
16.3.1 GSK Company Profile
16.3.2 GSK Antivirals Product Specification
16.3.3 GSK Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Johnson & Johnson
16.4.1 Johnson & Johnson Company Profile
16.4.2 Johnson & Johnson Antivirals Product Specification
16.4.3 Johnson & Johnson Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 F. Hoffmann-La Roche
16.5.1 F. Hoffmann-La Roche Company Profile
16.5.2 F. Hoffmann-La Roche Antivirals Product Specification
16.5.3 F. Hoffmann-La Roche Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Teva Pharmaceutical Industries
16.6.1 Teva Pharmaceutical Industries Company Profile
16.6.2 Teva Pharmaceutical Industries Antivirals Product Specification
16.6.3 Teva Pharmaceutical Industries Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Aurobindo Pharma
16.7.1 Aurobindo Pharma Company Profile
16.7.2 Aurobindo Pharma Antivirals Product Specification
16.7.3 Aurobindo Pharma Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Gilead Sciences
16.8.1 Gilead Sciences Company Profile
16.8.2 Gilead Sciences Antivirals Product Specification
16.8.3 Gilead Sciences Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Mylan
16.9.1 Mylan Company Profile
16.9.2 Mylan Antivirals Product Specification
16.9.3 Mylan Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 AbbVie
16.10.1 AbbVie Company Profile
16.10.2 AbbVie Antivirals Product Specification
16.10.3 AbbVie Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Cipla
16.11.1 Cipla Company Profile
16.11.2 Cipla Antivirals Product Specification
16.11.3 Cipla Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Dr Reddys
16.12.1 Dr Reddys Company Profile
16.12.2 Dr Reddys Antivirals Product Specification
16.12.3 Dr Reddys Antivirals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Antivirals Manufacturing Cost Analysis
17.1 Antivirals Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Antivirals
17.4 Antivirals Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Antivirals Distributors List
18.3 Antivirals Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Antivirals (2021-2026)
20.2 Global Forecasted Revenue of Antivirals (2021-2026)
20.3 Global Forecasted Price of Antivirals (2015-2026)
20.4 Global Forecasted Production of Antivirals by Region (2021-2026)
20.4.1 North America Antivirals Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Antivirals Production, Revenue Forecast (2021-2026)
20.4.3 Europe Antivirals Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Antivirals Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Antivirals Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Antivirals Production, Revenue Forecast (2021-2026)
20.4.7 Africa Antivirals Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Antivirals Production, Revenue Forecast (2021-2026)
20.4.9 South America Antivirals Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Antivirals Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Antivirals by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Antivirals by Country
21.2 East Asia Market Forecasted Consumption of Antivirals by Country
21.3 Europe Market Forecasted Consumption of Antivirals by Countriy
21.4 South Asia Forecasted Consumption of Antivirals by Country
21.5 Southeast Asia Forecasted Consumption of Antivirals by Country
21.6 Middle East Forecasted Consumption of Antivirals by Country
21.7 Africa Forecasted Consumption of Antivirals by Country
21.8 Oceania Forecasted Consumption of Antivirals by Country
21.9 South America Forecasted Consumption of Antivirals by Country
21.10 Rest of the world Forecasted Consumption of Antivirals by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer